Download full-text PDF |
Source |
---|
Fr J Urol
December 2024
Departments of Urology and Renal Transplantation, Nantes University Hospital Center, Nantes, France.
Introduction: Prostate cancer incidence in immunosuppressed transplant recipients increases as life expectancy improves in this population. However, the management of treatments and immunosuppressive (IS) regimens for solid organ transplant recipients diagnosed with prostate cancer remains poorly defined. Therefore, we conducted a multicentric study to investigate these parameters more thoroughly.
View Article and Find Full Text PDFWorld J Urol
December 2024
Department of Surgery, Division of Urology, American University of Beirut Medical Center, Beirut, Lebanon.
Investig Clin Urol
November 2024
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Purpose: Semantic segmentation is a fundamental part of the surgical application of deep learning. Traditionally, segmentation in vision tasks has been performed using convolutional neural networks (CNNs), but the transformer architecture has recently been introduced and widely investigated. We aimed to investigate the performance of deep learning models in segmentation in robot-assisted radical prostatectomy (RARP) and identify which of the architectures is superior for segmentation in robotic surgery.
View Article and Find Full Text PDFJ Coll Physicians Surg Pak
September 2024
Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan.
Objective: To determine the role of dexmedetomidine in potentiating the local anaesthetic efficacy of a low dose of bupivacaine when used as an adjuvant.
Study Design: A prospective, double-blind, randomised study. Place and Duration of the Study: Department of Anaesthesia, Sindh Institute of Urology and Transplantation, Karachi, Pakistan, from July 2021 to February 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!